文献速递慢性肾脏病水电解质与酸碱

成纤维细胞生长因子23与慢性肾脏病患者感染住院风险:CRIC研究

Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
PubMed 文献 · J Am Soc Nephrol · 2020-06-23

在3655例慢性肾脏病(CKD)患者中,基线血浆C端FGF23水平较高与首次因严重感染住院风险独立、单调相关。中位随访6.5年,29%患者因严重感染住院;最高四分位(≥235.9 RU/ml)相比最低四分位(<95.3 RU/ml)的HR为1.51(95%CI 1.23–1.85),log FGF23每增加1个标准差HR为1.26(95%CI 1.18–1.35),校正炎症和骨矿物质代谢标志物后仍显著。

要点

  • CKD患者FGF23水平升高与感染住院风险增加独立相关。
  • 最高四分位FGF23组感染住院风险是最低四分位组的1.51倍。
  • 关联在尿路感染、蜂窝织炎/骨髓炎、肺炎和菌血症/败血症亚型中一致。

核心结论

  • 在CKD人群中,较高的FGF23水平独立且单调地与感染住院风险增加相关。

研究设计与样本

  • 慢性肾脏病队列研究(CRIC),纳入3655例参与者,评估基线血浆C端FGF23水平与首次因严重感染住院的时间关系,使用多变量Cox模型估计风险比。

主要发现

  • 中位随访6.5年期间,1051例(29%)因严重感染住院。
  • 最高四分位(≥235.9 RU/ml)相比最低四分位(<95.3 RU/ml)的HR为1.51(95%CI 1.23–1.85)。
  • log FGF23每增加1个标准差,HR为1.26(95%CI 1.18–1.35)。
  • 关联在感染亚型(尿路感染482例、蜂窝织炎/骨髓炎422例、肺炎399例、菌血症/败血症280例)及人口学和临床亚组中一致。
  • 额外校正炎症标志物(IL-6、TNF-α、高敏C反应蛋白、纤维蛋白原、白蛋白)和骨矿物质代谢标志物(25-羟基维生素D、磷、钙、甲状旁腺激素)后,关联仍显著。

临床怎么用

  • 在CKD患者中,检测FGF23水平可能有助于识别感染住院风险较高的个体。
  • 对FGF23水平较高的CKD患者,应加强感染监测和预防措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through proinflammatory and vitamin D-suppressing pathways. Whether FGF23 is associated with risk of infection has not been evaluated in a CKD population. METHODS: In 3655 participants of the Chronic Renal Insufficiency Cohort study, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hospitalization with major infection, defined by hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia. Multivariable Cox models were used to estimate hazard ratios (HRs) and adjust for confounding. RESULTS: During a median follow-up of 6.5 years, 1051 individuals (29%) were hospitalized with major infection. Multivariable Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1.51; 95% CI, 1.23 to 1.85 with the highest quartile [≥235.9 RU/ml] versus lowest quartile [<95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23). The association was consistent across infection subtypes and demographic and clinical subgroups, and remained significant after additional adjustment for biomarkers of inflammation (IL-6, TNF-α, high-sensitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin D, phosphorus, calcium, and parathyroid hormone). The association was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cases), and bacteremia/septicemia (280 cases). CONCLUSIONS: Among individuals with CKD, higher FGF23 levels were independently and monotonically associated with an increased risk of hospitalization with infection.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ishigami J, Taliercio JT, Feldman HI, et al. Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2020. PMID: 32576601. doi:10.1681/ASN.2019101106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。